For 24 years, Marklund, a suburban nonprofit organization that serves children and adults with profound developmental disabilities, has hosted its "Top Hat Ball" as a live in-person fundraising event in Chicago. The COVID-19 pandemic caused a change in plans, but did not derail its success.
Published Mar 11, 2021
The Sisters of Notre Dame de Namur held a virtual prayer service February 12 to close out the 15th Anniversary Year of the assassination of Sister Dorothy Stang by wealthy landowners in the Brazilian Amazon. The prayer service included the participation of two Sisters who worked alongside Sister Dorothy: Sister Joan Krimm and Sister Jo Anne Depweg. Sister Elizabeth Bowyer also took part. Sister Elizabeth was the Ohio Province Provincial who received the news of Sister Dorothy’s death. The service was opened by Archbishop Daniel Schnurr, of the Cincinnati Archdiocese.
Discussion followed the prayer service, and included interviews of Sisters Jane Dwyer and Kathryn Webster, who also worked with Sister Dorothy and who remain in Brazil carrying on the work of empowering homesteaders in their struggles with wealthy landowners; a reflection by Samuel Clements, who produced a documentary on Sister Dorothy’s work in the year before she
Bicycle Therapeutics plc: Bicycle Therapeutics Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Corporate Update Toxin Conjugates (BTCs) and tumor targeted immune cell agonists (TICAs)
Cash of $136.0 million at December 31, 2020 expected to provide financial runway through multiple clinical milestones
First clinical trial site outside of the United States opened in ongoing Phase I/II trial of BT8009
Bicycle Therapeutics plc (NASDAQ: BCYC), a biotechnology company pioneering a new and differentiated class of therapeutics based on its proprietary bicyclic peptide (
Bicycle) technology, today reported financial results for the fourth quarter and full year ended December 31, 2020 and discussed recent corporate updates.
Published: Mar 09, 2021
–Announced new positive data in human experimental model of inflammation of EDP1815–
–Completed enrollment in Phase 2b dose-ranging trial for EDP1815 in psoriasis; full data set accelerated and now expected in 3Q 2021–
–Initiated Phase 1b clinical trial of EDP1867 in atopic dermatitis; data expected in 4Q 2021–
–Up to 8 clinical data readouts expected over next 18 months–
–Management to host conference call at 8:30 a.m. ET–
CAMBRIDGE, Mass., March 09, 2021 (GLOBE NEWSWIRE) Evelo Biosciences, Inc. (Nasdaq: EVLO), a clinical stage biotechnology company developing a new modality of orally delivered medicines, today reported financial results and business highlights for the fourth quarter and full year 2020.
Исторический визит: почему папа римский отправился в Ирак в разгар пандемии tass.ru - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tass.ru Daily Mail and Mail on Sunday newspapers.